The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 02, 2016

Filed:

Jan. 14, 2013
Applicant:

Postech Academy-industry Foundation, Gyeongsangbuk-do, KR;

Inventors:

Sung Ho Ryu, Gyeongsangbuk-do, KR;

A Ra Koh, Seoul, KR;

Mi Nam Lee, Busan, KR;

Hee Yoon Jeong, Gyeongsangbuk-do, KR;

Yong Ryoul Yang, Gyeongsangbuk-do, KR;

Pann Ghill Suh, Ulsan, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); A61K 31/713 (2006.01); A61K 31/19 (2006.01); A61K 31/7105 (2006.01); C12Q 1/42 (2006.01); C12N 15/113 (2010.01); G01N 33/50 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/713 (2013.01); A61K 31/19 (2013.01); A61K 31/7105 (2013.01); C12N 15/1137 (2013.01); C12Q 1/42 (2013.01); G01N 33/5023 (2013.01); A61K 38/00 (2013.01); C12N 2310/14 (2013.01); C12Y 301/03 (2013.01); G01N 2333/916 (2013.01); G01N 2500/04 (2013.01); G01N 2500/10 (2013.01); G01N 2800/042 (2013.01);
Abstract

The present invention relates to a pharmaceutical composition for preventing or treating diabetes or a complication of diabetes, which includes a TENC1 (tensin like C1 domain-containing phosphatase) expression or activity suppressor, and, more specifically, relates to a pharmaceutical composition for preventing or treating diabetes or a complication of diabetes, which either suppresses the degradation of IRS-1 (insulin receptor substrate-1) or suppresses the phosphorylation of IRS-1 due to the PTPase activity of TENC1. The pharmaceutical composition according to the present invention, which is for preventing or treating diabetes or a complication of diabetes and comprises the TENC1 expression or activity suppressor as an active ingredient, can be expected to be widely usable in preventing and treating diabetes or a complication of diabetes since the pharmaceutical composition can effectively prevent the muscular dystrophy and reduction in sugar adsorption that occur due to reduction in IRS-1 by suppressing degradation of IRS-1 caused by TENC1.


Find Patent Forward Citations

Loading…